openPR Logo
Press release

Colony Stimulating Factors Market Future Trends and Scope Analysis Report 2023-2030

02-22-2023 07:46 PM CET | IT, New Media & Software

Press release from: Insightace Analytics

/ PR Agency: Insightace Analytics
Colony Stimulating Factors Market Future Trends and Scope

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global Colony Stimulating Factors Market By Type (Macrophage-Colony-Stimulating Factor (M-CSF), Multiple-Colony-Stimulating Factor or Interleukin 3 (IL-3), Granulocyte-Macrophage-Colony-Stimulating Factor (GM-CSF) and Granulocyte-Colony-Stimulating Factor (G-CSF), drug (Pegfilgrastim, Tbo-filgrastim, Sargramostim and Filgrastim), Application (Aplastic Anemia, Bone Marrow Transplantation, Neutropenia, Neutropenia Associated with Chemotherapy, Neutropenia Associated with Radiation and Peripheral Progenitor Cell Transplantations), Dosage (Injection, Tablets, Capsules and Others), Route of Administration (Intravenous, Subcutaneous, Oral and Others), End-users ( Hospitals, Specialty Clinics, Homecare and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others)- Trends, Industry Competition Analysis, Revenue and Forecast To 2030."

The global Colony Stimulating Factors market is estimated to exhibit a CAGR of 7.27% during the forecast period. 

Get Free Sample Copy of Report :https://www.insightaceanalytic.com/request-sample/1382

Colony stimulating factors (CSFs) are hormone-like substances that promote the growth of immune cells that can fight infections. Our bodies produce CSFs from various cell types, which can then circulate throughout the body and bind to cells with specific CSF receptors. The ability of CSFs to stimulate immune cell synthesis makes them effective as drugs to increase the generation of white blood cells. Patients whose immune systems have been compromised by chemotherapy or particular immunodeficiency illnesses may be able to survive thanks to this drug. CSFs are utilized in the transplantation of blood stem cells and are also crucial drugs. The rise in governmental financing for healthcare, rising cancer prevalence and awareness of the availability of numerous cancer treatment options are the main drivers of expanding the global colony-stimulating factor market. Another important element for expanding the colony-stimulating factor market is the rising need for prophylactic colony-stimulating factor (CSF).

During the forecast period, market growth is anticipated to be fuelled by improvements and advances in genomics technology and healthcare. Ongoing R&D to create treatments for cancer control and its effects drive market growth. However, the market's expansion is hampered by onerous government restrictions on approving any new treatment choices. One of the main factors preventing the CSF market from expanding is the high price.

List of Prominent Players in the Colony Stimulating Factors Market:
ï‚·Intas Pharmaceuticals Ltd.
ï‚·Sanofi
ï‚·Novartis AG
ï‚·Teva Pharmaceutical Industries Ltd.
ï‚·Pfizer, Inc.
ï‚·GlaxoSmithKline plc
ï‚·Biocon
ï‚·Dr. Reddy's Laboratories Ltd.
ï‚·Amgen Inc.
ï‚·Merck KGaA
ï‚·Takeda Pharmaceutical Company Limited
ï‚·Thermo Fisher Scientific Inc.
ï‚·Stada Arzneimittel AG
ï‚·Emcure Pharmaceuticals Limited.
ï‚·Celltrion, Inc
ï‚·Biocad
ï‚·Coherus BioSciences
ï‚·Johnson & Johnson Private Limited
ï‚·Eli Lilly and Company.
ï‚·Abbott

Market Dynamics:
Drivers-
The market for colony-stimulating factors is expected to rise in response to the rising cancer incidence. Cancer is the second most common cause of mortality worldwide, responsible for about one death out of every six. By 2040, the International Agency for Research on Cancer (IARC) projects that population aging and expansion will result in 16.3 million cancer deaths and 27.5 million new cancer cases globally. More than 70% of cancer-related fatalities occur in low- and middle-income countries. G-CSF is a growth factor that aids in producing white blood cells in the bone marrow, lowering the danger of infection and sepsis. Granulocyte colony-stimulating factor (G-CSF) for prevention is in high demand, which is projected to fuel market expansion. The market for colony-stimulating factors will also grow due to efforts by both public and private groups to raise awareness of the availability of various cancer treatment options.

Challenges:
The market for colony-stimulating factors is anticipated to be constrained by its high price. The need for colony-stimulating factors will face difficulties due to a shortage of qualified workers and inadequate healthcare infrastructure in emerging nations. Additionally, colony-stimulating factors' adverse effects and strict government approval requirements for novel treatment alternatives will function as market restraints and hinder market growth.

Regional Trends:
The North America Colony Stimulating Factors market is expected to register a significant market share in revenue and is projected to grow at a high CAGR shortly due to the region's increasing cancer prevalence. Furthermore, the market's growth rate will be further accelerated by the expanding presence of significant important players and solid healthcare infrastructure. The expansion is also a result of improvements in clinical practice, access to cancer therapy, and cancer research inventions in the USA. Approximately 1,735,350 novel instances of cancer were reported in the US, according to the National Cancer Institute (NCI). As a result, North America's market for colony-stimulating factors grew. Besides, Asia Pacific had a substantial share in the Colony Stimulating Factors market due to increased healthcare costs and advancements in the region's healthcare system. The market is anticipated to develop due to the population's rising tobacco usage, changing lifestyles, and increasing cancer prevalence.

Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1382

Recent Developments:
In June 2019, A US-based pharmaceutical company named Pfizer Inc. purchased Array BioPharma Inc. for $48 per share in cash or roughly $11.4 billion for the entire organization. The innovative biopharmaceutical business of Pfizer is strengthened by this acquisition, which is predicted to hasten its growth trajectory over the long run.

Segmentation of Colony Stimulating Factors Market-
By Type-
ï‚·Macrophage-Colony-Stimulating Factor (M-CSF)
ï‚·Multiple-Colony-Stimulating Factor or Interleukin 3 (IL-3)
ï‚·Granulocyte-Macrophage-Colony-Stimulating Factor (GM-CSF)
ï‚·Granulocyte-Colony-Stimulating Factor (G-CSF)
By Drug-
ï‚·Pegfilgrastim
ï‚·Tbo-filgrastim
ï‚·Sargramostim
ï‚·Filgrastim
By Application-
ï‚·Aplastic Anemia
ï‚·Bone Marrow Transplantation
ï‚·Neutropenia
ï‚·Neutropenia Associated with Chemotherapy
ï‚·Neutropenia Associated with Radiation
ï‚·Peripheral Progenitor Cell Transplantations
By Dosage-
ï‚·Injection
ï‚·Tablets
ï‚·Capsule
ï‚·Others
By Route of Administration-
ï‚·Intravenous
ï‚·Subcutaneous
ï‚·Oral
ï‚·Others
By End-Users
ï‚·Hospitals
ï‚·Specialty Clinics
ï‚·Homecare
ï‚·Others
By Distribution Channel
ï‚·Hospital Pharmacy
ï‚·Retail Pharmacy
ï‚·Online Pharmacy
ï‚·Others
By Region-
North America-
ï‚·The US
ï‚·Canada
ï‚·Mexico
Europe-
ï‚·Germany
ï‚·The UK
ï‚·France
ï‚·Italy
ï‚·Spain
ï‚·Rest of Europe
Asia-Pacific-
ï‚·China
ï‚·Japan
ï‚·India
ï‚·South Korea
ï‚·South East Asia
ï‚·Rest of Asia Pacific
Latin America-
ï‚·Brazil
ï‚·Argentina
ï‚·Rest of Latin America
Middle East & Africa-
ï‚·GCC Countries
ï‚·South Africa
Rest of Middle East and Africa

For Customization: https://www.insightaceanalytic.com/customisation/1382

Corporate Office :
Office No.3050, 3rd Floor Marvel Fuego, Magarpatta Rd, Hadapsar, Pune, Maharashtra 411028

Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
info@insightaceanalytic.com

info@insightaceanalytic.com
North America:
+1 551 226 6109
Asia:
+91 79 72967118

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Colony Stimulating Factors Market Future Trends and Scope Analysis Report 2023-2030 here

News-ID: 2944347 • Views: …

More Releases from Insightace Analytics

Plastic Recycling Market Deep Research Report with Forecast to 2031
Plastic Recycling Market Deep Research Report with Forecast to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Plastic Recycling Market Size, Share & Trends Analysis Report By Material (PET, PP, HDPE, LDPE, PS, PVC), Application (Packaging, Automotive, Construction, Textiles) - Market Outlook And Industry Analysis 2031" The Global Plastic Recycling Market Size is valued at 42.06 billion in 2022 and is predicted to reach 77.19 billion by the year 2031 at a 7.17%…
Viral and Non-Viral Vector Manufacturing Market Size, Share and Scope Analysis to 2030
Viral and Non-Viral Vector Manufacturing Market Size, Share and Scope Analysis t …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Viral and Non-Viral Vector Manufacturing Market (Vector Type (Viral Vector (Adenoviral Vector, Retroviral Vector, Adeno-Associated Viral Vector, Lentiviral Vector, Vaccinia Viral Vector, Other Viral Vector), Non-Viral Vectors, (Plasmid DNA, Lipid-Based Non-Viral Vector, Polymer-Based Non-Viral Vector, Other Non-Viral Vector (Peptide-Based And Hybrid/Combination))), Diseases (Cancer, Genetic Disorder, And Infectious Diseases), Application (Gene Therapy (Viral Vector, Non-Viral…
The Lipid Nanoparticles (LNPs) CDMO Market Size, Share and Trends Analysis to 2030
The Lipid Nanoparticles (LNPs) CDMO Market Size, Share and Trends Analysis to 20 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Lipid Nanoparticles (LNPs) CDMO Market Focus on Nucleic Acids LNPs Segmented By Product (mRNA , Plasmid DNA (pDNA), siRNA, saRNA, microRNA, and Others), Scale Of Operation (Preclinical, Clinical , and Commercial), End-Users (Pharmaceutical Companies, Academic Research Institute, and Diagnostic Laboratories)- Trends, Industry Competition Analysis, Revenue and Forecast To 2030." According to the latest research by…
Green Hydrogen Market Size, Share and Trends Analysis Report 2023-2030
Green Hydrogen Market Size, Share and Trends Analysis Report 2023-2030
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Green Hydrogen Market Size, Share & Trends Analysis Report by Application (Oil and Gas, Industrial Feedstock, Mobility, Power Generation) And Technology (Proton Exchange Membrane Electrolyzer, Alkaline Electrolyzer, Anion Exchange Membrane, And Solid Oxide Electrolyzer)- Market Outlook and Industry Analysis 2031" According to company's newest research, the global green hydrogen market size was valued at US$…

All 5 Releases


More Releases for Colony

Colony Stimulating Factors Market Boosting Immunity, Bolstering Growth: The Rise …
Colony Stimulating Factors Market to Record an Exponential CAGR by 2030 - Exclusive Report by InsightAce Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Global Colony Stimulating Factors Market By Type (Macrophage-Colony-Stimulating Factor (M-CSF), Multiple-Colony-Stimulating Factor or Interleukin 3 (IL-3), Granulocyte-Macrophage-Colony-Stimulating Factor (GM-CSF) and Granulocyte-Colony-Stimulating Factor (G-CSF), drug (Pegfilgrastim, Tbo-filgrastim, Sargramostim and Filgrastim), Application (Aplastic Anemia, Bone Marrow Transplantation, Neutropenia, Neutropenia Associated with…
Colony Counters Market 2023
The report presents detailed information regarding the prominent players and potential competitors in the Colony Counters market. It includes comprehensive insights into their worldwide presence, economic performance, strategies, upcoming product releases, research and development initiatives, and a SWOT analysis. Additionally, the report analyses revenue share and contact details for each player. This comprehensive report aims to evaluate and forecast the market size for Fuel Monitoring Systems. It analyses revenue, growth rate,…
Automated Colony Picking Systems Market - Unleashing Precision in Research: Revo …
Newark, New Castle, USA - The latest report from Growth Plus Reports analyzes the production, potential applications, demand, major manufacturers, and SWOT analysis of the global Automated Colony Picking Systems Market. Automated Colony Picking Systems Market: https://www.growthplusreports.com/report/automated-colony-picking-systems-market/9147 The Automated Colony Picking Systems Market Report assists in determining the optimum distribution methods for certain products as well as possible markets for future product launches. The report also analyses the purchase and supply trends…
Global Automated Colony Counter Market Analysis (2020-2025)
Global Info Research offers a latest published report on Automated Colony Counter Analysis and Forecast 2020-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Automated Colony Counter Concentrate players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. Click to view the full report TOC, figure…
Colony Counters Market Trends and Forecast to 2026 - TMR
Colony counters estimate a liquid culture's density of microorganisms. They specify the number of microbial colonies present on sample plates (agar plate, slide, mini gel, or Petri dish.) for maximized working efficiency in the lab. They accelerate medical and biology research procedures that demand the examination of microorganism growth rates in food, environmental, pharmaceutical, veterinary, and clinical laboratories. They are capable of judging the sample concentration, antibiotic testing, exact reagent,…
Automated Colony Picking System Market Growth 2020-2025
Scope of the Report: The worldwide market for Automated Colony Picking System is expected to grow at a CAGR of roughly x% over the next five years, will reach x million US$ in 2024, from x million US$ in 2019, according to a new Global Info Research study. The report presents the market outlook for the Indian Phospho Gypsum product from the year 2019 to the year 2025. The report provides a definition of…